Amar­na rais­es €10M to push gene ther­a­py plat­form in­to clin­ic; Ed­i­tas Med­i­cine, AskBio join forces

Amar­na Ther­a­peu­tics — de­vel­op­ing an SV40-based gene de­liv­ery vec­tor plat­form called SVac — has raised €10 mil­lion. The round was led by Swedish in­vest­ment com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.